Periostin was originally called osteoblast specific factor-2 and in this study we have shown that periostin is highly expressed in reparative lesions associated with osteoid/woven bone formation, such as fracture callus and myositis ossificans as well as in benign and malignant bone-forming tumours. This evidence concerns the gene POSTN and neoplasm.